• Hematologic Malignancy Center

    Dr. Lewis Silverman with Patient

    The Hematologic Malignancy Center at Dana-Farber/Boston Children's is one of the top centers of its kind in the world. We offer specialized programs for the treatment of leukemia, lymphoma, histiocytosis and lymphadenopathy. Our center played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 90 percent for pediatric acute lymphoblastic leukemia, and we continue to lead high-impact clinical trials designed to increase cure rates and decrease treatment-related toxicities for long-term survivors.

    Highlights of the Hematologic Malignancy Center include:

    • Highly specialized hematologist/oncologists who are world leaders in their field
    • Quick and accurate diagnosis from our pediatric hematopathology service, one of the few dedicated pediatric programs in the U.S.
    • Advanced diagnostic techniques, including multiparameter flow cytometry and next generation sequencing genetic testing to detect key mutations that might be treated through targeted therapy (precision medicine)
    • Specialized methods to detect minimal residual disease (levels of disease that cannot be seen under a microscope)
    • Cutting-edge immunotherapies, including CAR T-cell therapy for relapsed ALL
    • Outpatient pediatric anesthesia program to minimize pain and discomfort associated with diagnostic and therapeutic procedures (including bone marrow aspirates/biopsies and lumbar punctures)
    • Innovative treatment options, including a large portfolio of innovative, early phase clinical trials for patients with relapsed and refractory cancer
    • Access to an internationally recognized pediatric Stem Cell Transplant Center
    • Innovative programs to improve quality of life during and after treatment, including the back-to-school program, home hydration program (to minimize time spent in the hospital receiving chemotherapy) and multiple, age-appropriate activities and outings with child-life specialists
    • fertility preservation small

      Fertility Preservation

      A specialized program for patients receiving cancer treatment who have experienced a decrease or loss of reproductive function.

    • survivor small

      Survivorship Services

      Providing care and advocacy for survivors of childhood cancer through ongoing education, support and research on the long-term effects of cancer treatments.

    • psychosocial oncology

      Psychosocial Services

      Social workers, psychologists and resource specialists offering help with the social, emotional, and psychological aspects of caring for children with cancer.

  • Ranked #1 for Cancer Care

    U.S. News Best Children's Hospitals logoU.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.

  • Sarah Levin's Story

    Sarah Levine Leukemia Story

    Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story in her own words on the Boston Children's Hospital Blog Thriving.

  • Our Affiliations

    HMS Callout FAD 

    Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.